Deep Track Capital Increases Stake in Structure Therapeutics by $11.5 Million
On May 15, 2026, Deep Track Capital disclosed an additional purchase of 168,066 shares of Structure Therapeutics (GPCR) valued at approximately $11.5 million during the first quarter. The fund now holds a 3.37% stake in its U.S. equity portfolio as of March 31, 2026.
Tickers: $GPCR